Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(48)
•••
Post by ISAloser247on Nov 06, 2012 9:40am
254 Views
Post# 20566599

PROMISING NEWS? JUST LIKE LAST SHAREHOLDER

PROMISING NEWS? JUST LIKE LAST SHAREHOLDER

LETTER???  I really don't want to urinate on Your vines, vino-man,  but HOW PROMISING CAN ANYTHING DR> FOSTER SAYS , HAVE ANY MERIT!  EVERY VIRUS THAT IS MENTIONED HAS A SUCCESSFUL, ALREADY ON THE MARKET, REMEDY!!   WHAT HAPPENED TO THE KIDNEY TRANSPLANTATION FOCUS OF THE 'DEAR SHAREHOLDER'?  I ALWAYS GET A KICK , WHEN THE MUTTON_MAN THROWS IN THE """BILLION DOLLAR MARKET"""" ...........something ISA losers 24/7  will never be able to take advantage of!!!!!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities